<DOC>
	<DOCNO>NCT01350102</DOCNO>
	<brief_summary>The purpose study investigate relationship hemoglobin A1c diabetic wound healing . Additionally , comparison two wound dressing , AmeriGelÂ® ( Amerx Health Care Corp. , Clearwater , FL ) Bacitracin , without vitamin C supplementation , do evaluate impact time wound closure .</brief_summary>
	<brief_title>The Relationship Hemoglobin A1c Diabetic Wound Healing</brief_title>
	<detailed_description>This prospective randomized control study evaluate relationship hemoglobin A1c diabetic wound healing . Length time wound closure compare use four treatment option .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<criteria>&gt; 18 year age Diabetic ( Type I Type II ) Ulceration foot least one centimeter width/length Ulceration least 0.2 centimeter depth Ulceration width/length &gt; 7.5 centimeter Wound depth &gt; 1.25 centimeter Purulent , excessive drainage and/or sign infection ( i.e . erythema , edema , warmth ) Inability provide inform consent Inability swallow pill ( vitamin C supplement ) Patients concurrent renal problem Patients medication contraindication Vitamin C and/or topical wound dressing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Adult</keyword>
</DOC>